BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 34969693)

  • 21. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between glycaemic outcome and BMI in Danish children with type 1 diabetes in 2000-2018: a nationwide population-based study.
    Ibfelt EH; Vistisen D; Falberg Rønn P; Pørksen S; Madsen M; Kremke B; Svensson J
    Diabet Med; 2021 Mar; 38(3):e14401. PubMed ID: 32918312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten Years of Improving Glycemic Control in Pediatric Diabetes Care: Data From the Norwegian Childhood Diabetes Registry.
    Bratke H; Biringer E; Ushakova A; Margeirsdottir HD; Kummernes SJ; Njølstad PR; Skrivarhaug T
    Diabetes Care; 2024 Jul; 47(7):1122-1130. PubMed ID: 38648259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
    Duarte V; Mota B; Ferreira S; Costa C; Correia CC
    Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience.
    Dorchy H; Roggemans MP; Willems D
    Diabetes Care; 1997 Jan; 20(1):2-6. PubMed ID: 9028684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry.
    Biester T; Eckert A; Becker M; Boettcher C; Golembowski S; Heidtmann B; Klinkert C; Müther S; Rami-Merhar B; Holl RW
    Diabetes Technol Ther; 2023 Nov; 25(11):774-781. PubMed ID: 37668604
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy.
    Matejko B; Skupien J; Mrozińska S; Grzanka M; Cyganek K; Kiec-Wilk B; Malecki MT; Klupa T
    Endocrine; 2015 Feb; 48(1):164-9. PubMed ID: 24798448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registry.
    James S; Perry L; Lowe J; Harris M; Craig ME;
    Pediatr Diabetes; 2022 Sep; 23(6):736-741. PubMed ID: 35561056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trajectories of Body Mass Index from Childhood to Young Adulthood among Patients with Type 1 Diabetes-A Longitudinal Group-Based Modeling Approach Based on the DPV Registry.
    Prinz N; Schwandt A; Becker M; Denzer C; Flury M; Fritsch M; Galler A; Lemmer A; Papsch M; Reinehr T; Rosenbauer J; Holl RW
    J Pediatr; 2018 Oct; 201():78-85.e4. PubMed ID: 29937081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    Libman IM; Miller KM; DiMeglio LA; Bethin KE; Katz ML; Shah A; Simmons JH; Haller MJ; Raman S; Tamborlane WV; Coffey JK; Saenz AM; Beck RW; Nadeau KJ;
    JAMA; 2015 Dec; 314(21):2241-50. PubMed ID: 26624824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.
    Teló GH; Dougher CE; Volkening LK; Katz ML; Laffel LM
    Diabet Med; 2018 Oct; 35(10):1355-1363. PubMed ID: 29855077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the use of diabetes technology with HbA1c and BMI-SDS in an international cohort of children and adolescents with type 1 diabetes: The SWEET project experience.
    Marigliano M; Eckert AJ; Guness PK; Herbst A; Smart CE; Witsch M; Maffeis C;
    Pediatr Diabetes; 2021 Dec; 22(8):1120-1128. PubMed ID: 34716736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up.
    Yazidi M; Mahjoubi S; Oueslati I; Chaker F; Chihaoui M
    Arch Endocrinol Metab; 2022 Apr; 66(2):222-228. PubMed ID: 35315990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of deprivation, ethnicity, and insulin pump therapy on developmental trajectories of diabetes control in COB type 1 diabetes.
    Viner RM; White B; Amin R; Peters C; Khanolkar A; Christie D; Hindmarsh PC
    Pediatr Diabetes; 2017 Aug; 18(5):384-391. PubMed ID: 27534520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Trajectories of Metabolic Control From Childhood to Young Adulthood in Type 1 Diabetes From a Large German/Austrian Registry: A Group-Based Modeling Approach.
    Schwandt A; Hermann JM; Rosenbauer J; Boettcher C; Dunstheimer D; Grulich-Henn J; Kuss O; Rami-Merhar B; Vogel C; Holl RW;
    Diabetes Care; 2017 Mar; 40(3):309-316. PubMed ID: 28007778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents.
    Vollbach H; Auzanneau M; Reinehr T; Wiegand S; Schwab KO; Oeverink R; Froehlich-Reiterer E; Woelfle J; De Beaufort C; Kapellen T; Gohlke B; Holl RW
    J Diabetes; 2021 Nov; 13(11):930-939. PubMed ID: 34184423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term insulin pump treatment in girls with type 1 diabetes and eating disorders--is it feasible?
    Pinhas-Hamiel O; Graph-Barel C; Boyko V; Tzadok M; Lerner-Geva L; Reichman B
    Diabetes Technol Ther; 2010 Nov; 12(11):873-8. PubMed ID: 20879965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
    Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
    Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Low-dose Dapagliflozin in Young People with Type 1 Diabetes.
    Urakami T; Yoshida K; Suzuki J
    Intern Med; 2023; 62(2):177-186. PubMed ID: 36642532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.